BRCA1,TP53, andCHEK2germline mutations in uterine serous carcinoma-Reference-Cited by-同舟云学术

BRCA1,TP53, andCHEK2germline mutations in uterine serous carcinoma

Published:2012-07-18 Issue:2 Volume:119 Page:332-338
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Pennington Kathryn P.,Walsh Tom,Lee Ming,Pennil Christopher,Novetsky Akiva P.,Agnew Kathy J.,Thornton Anne,Garcia Rochelle,Mutch David,King Mary-Claire,Goodfellow Paul,Swisher Elizabeth M.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.27720/fullpdf

Reference28 articles.

1. Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing;Walsh;Proc Natl Acad Sci U S A.,2011

2. Management of women with uterine papillary serous cancer: a Society of Gynecologic Oncology (SGO) review;Boruta;Gynecol Oncol.,2009

3. Uterine serous and grade 3 endometrioid carcinomas: is there a survival difference?;Boruta;Cancer.,2004

4. Is uterine serous papillary carcinoma a BRCA1-related disease? Case report and review of the literature;Hornreich;Gynecol Oncol.,1999

5. High incidence of BRCA1-2 germline mutations, previous breast cancer and familial cancer history in Jewish patients with uterine serous papillary carcinoma;Biron-Shental;Eur J Surg Oncol.,2006

Cited by 99 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients;Gynecologic Oncology Reports;2024-10

2. Advantages of Robotic Surgery for Patients of Reproductive Age with Endometrial Cancer;Life;2024-09-03

3. Association between missense variants of uncertain significance in the CHEK2 gene and hereditary breast cancer: a cosegregation and bioinformatics analysis;Frontiers in Genetics;2024-02-27

4. High-Grade Endometrial Carcinoma;Gynecologic and Obstetric Pathology;2024

5. Endometrial Carcinoma. Low-Grade Endometrioid Carcinoma;Gynecologic and Obstetric Pathology;2024